Hysingla ER and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Hysingla ER and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hysingla ER-Insulin degludec
- Hysingla ER-Insulin Degludec (U-100) Prefilled Pens
- Hysingla ER-Insulin Degludec (U-100) Vials
- Hysingla ER-Insulin Degludec (U-200) Prefilled Pens
- Hysingla ER-Insulin degludec and liraglutide
- Hysingla ER-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Hyskon high molecular weight
- Insulin aspart, recombinant Subcutaneous-Hytone
- Insulin aspart, recombinant Subcutaneous-Hytrin
- Insulin aspart, recombinant Subcutaneous-Hytrin capsules
- Insulin aspart, recombinant Subcutaneous-Hyzaar
- Insulin aspart, recombinant Subcutaneous-Hyzine